{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:38:18Z","timestamp":1761676698765,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jogc.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Obstetrics and Gynaecology Canada"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.jogc.2018.05.030","type":"journal-article","created":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T02:13:52Z","timestamp":1540520032000},"page":"647-652","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Outcomes During Early Implementation of Mifepristone-Buccal Misoprostol Abortions up to 63 Days of Gestation in a Canadian Clinical Setting"],"prefix":"10.1016","volume":"41","author":[{"given":"Sarah","family":"Warden","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inna","family":"Genkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Hum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheila","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jogc.2018.05.030_bib0010","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.contraception.2011.06.009","article-title":"Induced abortion in Canada 1974\u20132005: trends over the first generation with legal access","volume":"85","author":"Norman","year":"2012","journal-title":"Contraception"},{"author":"Abortion Rights Coalition of Canada","key":"10.1016\/j.jogc.2018.05.030_bib0015"},{"issue":"11","key":"10.1016\/j.jogc.2018.05.030_bib0020","article-title":"Medical methods for first trimester abortion","author":"Kulier","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jogc.2018.05.030_bib0025","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/AOG.0000000000000897","article-title":"Mifepristone with buccal misoprostol for medical abortion: a systematic review","volume":"126","author":"Chen","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2018.05.030_bib0030","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/AOG.0b013e31818d8eb4","article-title":"Two distinct oral routes of misoprostol in mifepristone medical abortion: a randomized controlled trial","volume":"112","author":"Winikoff","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2018.05.030_bib0035","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1097\/AOG.0b013e31826c315f","article-title":"Extending outpatient medical abortion services through 70days of gestational age","volume":"120","author":"Winikoff","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2018.05.030_bib0040","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3109\/13625187.2011.555568","article-title":"Mifepristone followed by home administration of buccal misoprostol for medical abortion up to 70days of amenorrhoea in a general practice in Cura\u00e7ao","volume":"16","author":"Boersma","year":"2011","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.jogc.2018.05.030_bib0045","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/AOG.0b013e318224d110","article-title":"Effectiveness and acceptability of medical abortion provided through telemedicine","volume":"118","author":"Grossman","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2018.05.030_bib0050","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.contraception.2011.12.012","article-title":"A randomized controlled trial of different buccal misoprostol doses in mifepristone medical abortion","volume":"86","author":"Chong","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.jogc.2018.05.030_bib0055","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/ajo.12608","article-title":"Efficacy and safety of mifepristone-buccal misoprostol for early medical abortion in an Australian clinical setting","volume":"57","author":"Goldstone","year":"2017","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.jogc.2018.05.030_bib0060","doi-asserted-by":"crossref","first-page":"282","DOI":"10.5694\/mja12.10297","article-title":"Early medical abortion using low-dose mifepristone followed by buccal misoprostol: a large Australian observational study","volume":"197","author":"Goldstone","year":"2012","journal-title":"Med J Aust"},{"key":"10.1016\/j.jogc.2018.05.030_bib0065","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.contraception.2012.09.022","article-title":"A randomized clinical trial comparing the short-term side effects of sublingual and buccal routes of misoprostol administration for medical abortions up to 63 days' gestation","volume":"87","author":"Chai","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.jogc.2018.05.030_bib0070","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3109\/13625187.2014.933956","article-title":"Acceptability and feasibility of mifepristone medical abortion in the early first trimester in Azerbaijan","volume":"19","author":"Louie","year":"2014","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.jogc.2018.05.030_bib0075","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/AOG.0000000000000050","article-title":"Acceptability and feasibility of phone follow-up after early medical abortion in Vietnam: a randomized controlled trial","volume":"123","author":"Ngoc","year":"2014","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2018.05.030_bib0080","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.contraception.2015.01.005","article-title":"Efficacy and safety of medical abortion using mifepristone and buccal misoprostol through 63 days","volume":"91","author":"Gatter","year":"2015","journal-title":"Contraception"},{"key":"10.1016\/j.jogc.2018.05.030_bib0085","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijgo.2014.04.012","article-title":"Efficacy and acceptability of a mifepristone-misoprostol combined regimen for early induced abortion among women in Mexico City","volume":"127","author":"Pe\u00f1a","year":"2014","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.jogc.2018.05.030_bib0090","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jogc.2016.01.002","article-title":"Medical abortion","volume":"38","author":"Costescu","year":"2016","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2018.05.030_bib0095","first-page":"e209","article-title":"Abortion health services in Canada: results of a 2012 national survey","volume":"62","author":"Norman","year":"2016","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.jogc.2018.05.030_bib0100","first-page":"776","article-title":"Update in current care guidelines: induced abortion","volume":"129","year":"2013","journal-title":"Duodecim"},{"key":"10.1016\/j.jogc.2018.05.030_bib0105","doi-asserted-by":"crossref","first-page":"j2011","DOI":"10.1136\/bmj.j2011","article-title":"Self reported outcomes and adverse events after medical abortion through online telemedicine: population based study in the Republic of Ireland and Northern Ireland","volume":"357","author":"Aiken","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.jogc.2018.05.030_bib0110","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.contraception.2014.09.009","article-title":"Can women determine the success of early medical termination of pregnancy themselves?","volume":"91","author":"Cameron","year":"2015","journal-title":"Contraception"},{"key":"10.1016\/j.jogc.2018.05.030_bib0115","article-title":"Advantages by medical abortions at home in the first trimester","volume":"176","author":"Bertelsen","year":"2014","journal-title":"Ugeskr Laeger"},{"author":"SOGC","key":"10.1016\/j.jogc.2018.05.030_bib0120"},{"key":"10.1016\/j.jogc.2018.05.030_bib0125","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.contraception.2016.04.013","article-title":"Medical abortion reporting of efficacy: the MARE guidelines","volume":"94","author":"Creinin","year":"2016","journal-title":"Contraception"},{"key":"10.1016\/j.jogc.2018.05.030_bib0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0010-7824(96)00252-1","article-title":"The efficacy and tolerance of mifepristone and prostaglandin in termination of pregnancy of less than 63days gestation; UK Multicentre Study\u2013final results","volume":"55","year":"1997","journal-title":"Contraception"},{"key":"10.1016\/j.jogc.2018.05.030_bib0135","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1056\/NEJM199804303381801","article-title":"Early pregnancy termination with mifepristone and misoprostol in the United States","volume":"338","author":"Spitz","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jogc.2018.05.030_bib0140","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0010-7824(02)00512-7","article-title":"Early abortion services in the United States: a provider survey","volume":"67","author":"Benson","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.jogc.2018.05.030_bib0145","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.0001-6349.2004.00368.x","article-title":"Role of routine ultrasonography in monitoring the outcome of medical abortion in a clinical setting","volume":"83","author":"Acharya","year":"2004","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.jogc.2018.05.030_bib0150","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/uog.6404","article-title":"Endometrial thickness following medical abortion is not predictive of subsequent surgical intervention","volume":"34","author":"Reeves","year":"2009","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.jogc.2018.05.030_bib0155","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/AOG.0b013e3181c996f3","article-title":"Alternatives to a routine follow-up visit for early medical abortion","volume":"115","author":"Clark","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2018.05.030_bib0160","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0140-6736(14)61054-0","article-title":"Clinical follow-up compared with self-assessment of outcome after medical abortion: a multicentre, non-inferiority, randomised, controlled trial","volume":"385","author":"Oppegaard","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jogc.2018.05.030_bib0165","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.contraception.2015.05.013","article-title":"Comparison of remote and in-clinic follow-up after methotrexate\/misoprostol abortion","volume":"92","author":"Dunn","year":"2015","journal-title":"Contraception"},{"key":"10.1016\/j.jogc.2018.05.030_bib0170","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.contraception.2009.08.008","article-title":"Feasibility of telephone follow-up after medical abortion","volume":"81","author":"Perriera","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.jogc.2018.05.030_bib0175","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3122\/jabfm.16.4.290","article-title":"Medical abortion in family practice: a case series","volume":"16","author":"Prine","year":"2003","journal-title":"J Am Board Fam Pract"}],"container-title":["Journal of Obstetrics and Gynaecology Canada"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216318304687?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216318304687?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:33:21Z","timestamp":1761665601000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1701216318304687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S1701216318304687"],"URL":"https:\/\/doi.org\/10.1016\/j.jogc.2018.05.030","relation":{},"ISSN":["1701-2163"],"issn-type":[{"type":"print","value":"1701-2163"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes During Early Implementation of Mifepristone-Buccal Misoprostol Abortions up to 63 Days of Gestation in a Canadian Clinical Setting","name":"articletitle","label":"Article Title"},{"value":"Journal of Obstetrics and Gynaecology Canada","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogc.2018.05.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Society of Obstetricians and Gynaecologists of Canada\/La Soci\u00e9t\u00e9 des obst\u00e9triciens et gyn\u00e9cologues du Canada. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}